{"id":264340,"date":"2018-09-13T01:42:03","date_gmt":"2018-09-13T01:42:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=264340"},"modified":"2018-09-13T01:42:03","modified_gmt":"2018-09-13T01:42:03","slug":"circulating-tumor-cells-market-2018-global-key-players-trends-share-industry-size-segmentation-opportunities-forecast-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/circulating-tumor-cells-market-2018-global-key-players-trends-share-industry-size-segmentation-opportunities-forecast-to-2025_264340.html","title":{"rendered":"Circulating Tumor Cells Market 2018 Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2025"},"content":{"rendered":"
\n
“Global Circulating Tumor Cells Market”<\/div>\n<\/div>\n
Market Analysis Research Report On \u201cGlobal Circulating Tumor Cells Market 2018 Industry Growth, Size, Trends, Share, Opportunities And Forecast To 2025\u201d To Their Research Database.<\/div>\n

Global Circulating Tumor Cells Market <\/strong><\/p>\n

This report studies the Circulating Tumor Cells market status and outlook of global and major regions, from angles of players, regions, product and end Application\/industries; this report analyzes the top players in global and major regions, and splits the Circulating Tumor Cells market by product and Application\/end industries.<\/p>\n

In 2017, the global circulating tumor cells market size was 731.47 million US$ and it is expected to reach 3231.85 million US$ by the end of 2025, with a CAGR of 20.66% during 2019-2025.<\/p>\n

Request a Sample Report @<\/strong> https:\/\/www.wiseguyreports.com\/sample-request\/3267428-global-circulating-tumor-cells-market-size-status-and-forecast-2025<\/strong><\/a><\/p>\n

This report focuses<\/strong> on the global top players, covered 
Menarini-Silicon Biosystems 
Qiagen (Adnagen) 
Advanced Cell Diagnostics 
ApoCell 
Epic Sciences 
Greiner Bio-one GmbH 
Cynvenio 
SurExamBio-Tech 
Fluxion Biosciences 
Ikonisys 
Hangzhou Watson Biotech 
Biocept 
CytoTrack 
Guangzhou Wondfo Biotech 
Celsee 
Clearbridge Biomedics 
ANGLE plc<\/p>\n

Geographically,<\/strong> this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of circulating tumor cells in these regions, from 2013 to 2025 (forecast), covering 
North America 
Europe 
China 
APEC<\/p>\n

On the basis of product<\/strong>, the circulating tumor cells market is primarily split into 
CTC Enrichment 
CTC Detection 
CTC Analysis<\/p>\n

On the basis on the end users\/applications,<\/strong> this report covers 
Breast Cancer 
Prostate Cancer 
Colorectal Cancer 
Lung Cancer 
Other<\/p>\n

Table of Contents-Key Points Covered<\/strong><\/p>\n

1 Industry Overview 1 
    1.1 Circulating Tumor Cells Market Overview 1 
      1.1.1 Circulating Tumor Cells Product Scope 1 
      1.1.2 Market Status and Outlook 2 
    1.2 Global Circulating Tumor Cells Market Size and Analysis by Regions (2013-2018) 2 
      1.2.1 United States Circulating Tumor Cells Market Status and Outlook 4 
      1.2.2 Europe Circulating Tumor Cells Market Status and Outlook 5 
      1.2.3 Japan Circulating Tumor Cells Market Status and Outlook 6 
      1.2.4 China Circulating Tumor Cells Market Status and Outlook 7 
      1.2.5 RoA Circulating Tumor Cells Market Status and Outlook 8 
      1.2.6 RoW Circulating Tumor Cells Market Status and Outlook 9 
    1.3 Classification of Circulating Tumor Cells by Product 9 
      1.3.1 Global Circulating Tumor Cells Revenue (Million USD) and Growth Comparison by Product (2013-2025) 9 
      1.3.2 Global Circulating Tumor Cells Revenue (Million USD) Market Share by Product in 2017 11 
      1.3.3 CTC Enrichment 12 
      1.3.4 CTC Detection 13 
      1.3.5 CTC Analysis 13 
    1.4 Circulating Tumor Cells Market by End Users\/Application 14 
      1.4.1 Breast Cancer Diagnosis and Treatment 15 
      1.4.2 Prostate Cancer Diagnosis and Treatment 16 
      1.4.3 Colorectal Cancer Diagnosis and Treatment 17 
      1.4.4 Lung Cancer Diagnosis and Treatment 18 
    1.5 Macroscopic Indicator 20 
      1.5.1 GDP for Major Regions 20 
      1.5.2 Population and Labor Considered for Forecast 22 
      1.5.3 Disposable Income Considered for Forecast 24 
2 Global Circulating Tumor Cells Competition Analysis by Players 26 
    2.1 Global Circulating Tumor Cells Market Size (Million USD) by Players (2017-2018) 26 
    2.2 Competitive Status 30 
3 Company (Top Players) Profiles and Key Data 31 
    3.1 Menarini-Silicon Biosystems 31 
      3.1.1 Company Basic Information, Key Products and Sales Area 31 
      3.1.2 Circulating Tumor Cells Product Overview 32 
      3.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 33 
    3.2 Qiagen (Adnagen) 33 
      3.2.1 Company Basic Information, Key Products and Sales Area 33 
      3.2.2 Circulating Tumor Cells Product Information 34 
      3.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 35 
    3.3 Advanced Cell Diagnostics 35 
      3.3.1 Company Basic Information, Key Products and Sales Area 35 
      3.3.2 Circulating Tumor Cells Product Overview 36 
      3.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 36 
    3.4 ApoCell 37 
      3.4.1 Company Basic Information, Key Products and Sales Area 37 
      3.4.2 Circulating Tumor Cells Product Overview 38 
      3.4.3 ApoCell Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 38 
    3.5 Epic Sciences 39 
      3.5.1 Company Basic Information, Key Products and Sales Area 39 
      3.5.2 Circulating Tumor Cells Product Overview 40 
      3.5.3 Epic Sciences Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 40 
    3.6 Greiner Bio-one GmbH 41 
      3.6.1 Company Basic Information, Key Products and Sales Area 41 
      3.6.2 Circulating Tumor Cells Product Overview 42 
      3.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 43 
    3.7 Cynvenio 43 
      3.7.1 Company Basic Information, Key Products and Sales Area 43 
      3.7.2 Circulating Tumor Cells Product Overview 44 
      3.7.3 Cynvenio Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 44 
    3.8 SurExamBio-Tech 45 
      3.8.1 Company Basic Information, Key Products and Sales Area 45 
      3.8.2 Circulating Tumor Cells Product Overview 46 
      3.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 47 
    3.9 Fluxion Biosciences 47 
      3.9.1 Company Basic Information, Key Products and Sales Area 47 
      3.9.2 Circulating Tumor Cells Product Overview 48 
      3.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue and Gross Margin (2017-2018) 49 
    3.10 Ikonisys 50 <\/p>\n

Continued….<\/p>\n

Complete Report Details @<\/strong> https:\/\/www.wiseguyreports.com\/reports\/3267428-global-circulating-tumor-cells-market-size-status-and-forecast-2025<\/strong><\/a><\/p>\n

 <\/strong><\/p>\n

 <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Global Circulating Tumor Cells Market” Market Analysis Research Report On \u201cGlobal Circulating Tumor Cells Market 2018 Industry Growth, Size, Trends, Share, Opportunities And Forecast To 2025\u201d To Their Research Database. Global Circulating Tumor Cells Market This report studies the Circulating … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-264340","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/264340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=264340"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/264340\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=264340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=264340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=264340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}